Identification of a Novel Immune-Gene Signature with Prognostic Value in Patients with Head and Neck Cancer: A Pilot Study
Biochemical Genetics · 2026
DOI: 10.1007/s10528-024-11017-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Genetics, 2026. Verfasst von Panagiota Batsaki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Immunology and Immunotherapy Center, Cancer Research Center, Saint Savas Cancer Hospital, 11522, Athens, Greece. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Biomarkers, Tumor, Carcinoma, Squamous Cell, Transcriptome. Die Arbeit nennt 40 Literaturangaben. Gefördert von: European Regional Development Fund and Greek funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call Research-Cr…, European Regional Development Fund and Greek funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call Research–Cr….
Abstract (Originalsprache)
The tumor microenvironment has a significant input on prognosis and also for predicting clinical outcomes in various types of cancers. However, tumor tissue is not always available, thus, rendering peripheral blood a preferable alternative in the search for prognostic and predictive gene signatures. Head and neck squamous cell carcinoma (HNSCC) constitutes a quite heterogeneous disease characterized by poor prognosis. Therefore, the discovery of novel therapeutics based on prognostic gene signatures for effective disease governance is of paramount importance. In this study, we report for the first time an immune-gene signature identified in the peripheral blood of HNSCC patients comprising five genes (CLEC4C, IL23A, LCK, LY9, and CD19) which were more than threefold downregulated as compared to healthy individuals and were associated with poor prognosis. By performing analyses of HNSCC tumor samples from The Cancer Genome Atlas (TCGA) database, we discovered that decreased expression of these genes, both as single genes and as a 5-gene signature (5-GS), was significantly correlated with worse overall survival (OS). Our data show that the levels of expression of the 5-GS represent an immune profile predicting OS in patients with HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Immunology and Immunotherapy Center, Cancer Research Center, Saint Savas Cancer Hospital, 11522, Athens, Greece.
- Department of Otorhinolaryngology/Head & Neck Surgery, Saint Savas Cancer Hospital, 11522, Athens, Greece.
- Department of Transfusion Service and Clinical Hemostasis, Saint Savas Cancer Hospital, 11522, Athens, Greece.
- Department of Radiotherapy/Oncology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
- Biomedical Applications Unit, Institute of Chemical Biology, National Hellenic Research Foundation (NHRF), 11635, Athens, Greece.
- Cancer Immunology and Immunotherapy Center, Cancer Research Center, Saint Savas Cancer Hospital, 11522, Athens, Greece. mgoulielmaki@ciic.gr.
Förderung
- European Regional Development Fund and Greek funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call Research-Cr…
- European Regional Development Fund and Greek funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call Research–Cr…
Zitieren
APA
Batsaki, P., Fortis, S. P., Gritzapis, A. D., Razou, A., Sakellaridis, A. C., Grouzi, E., Moschandreou, D., Koukourakis, M. I., Zoumpourlis, V., Baxevanis, C. N., & Goulielmaki, M. (2026). Identification of a Novel Immune-Gene Signature with Prognostic Value in Patients with Head and Neck Cancer: A Pilot Study. Biochemical Genetics. https://doi.org/10.1007/s10528-024-11017-8
Vancouver
Batsaki P, Fortis SP, Gritzapis AD, Razou A, Sakellaridis AC, Grouzi E, et al. Identification of a Novel Immune-Gene Signature with Prognostic Value in Patients with Head and Neck Cancer: A Pilot Study. Biochemical Genetics. 2026. doi:10.1007/s10528-024-11017-8
BibTeX
@article{Batsaki2026,
author = {Batsaki, Panagiota and Fortis, Sotirios P and Gritzapis, Angelos D and Razou, Andriana and Sakellaridis, Athanasios C and Grouzi, Elisavet and Moschandreou, Dimitra and Koukourakis, Michael I and Zoumpourlis, Vassilios and Baxevanis, Constantin N and Goulielmaki, Maria},
title = {Identification of a Novel Immune-Gene Signature with Prognostic Value in Patients with Head and Neck Cancer: A Pilot Study},
journal = {Biochemical Genetics},
year = {2026},
doi = {10.1007/s10528-024-11017-8}
}
EUVIMED